FDA Clears Lumipulse Procalcitonin Assay
Monitoring procalcitonin levels assists with antibiotic stewardship and risk assessment of lower respiratory tract infections and sepsis.
Read More
Search Results for: infectious diseases
Wellcome Sanger Institute Sequences Reference Genomes of 3,000 Dangerous Bacteria
Dysentery, gonorrhea, and plague are among the collection of bacterial genomes now publicly available through a collaboration with Pacific Biosciences.
Read More
FDA Clears T2Bacteria Panel for the Detection of Sepsis-Causing Pathogens
The first FDA-cleared test to identify sepsis-causing bacteria from whole blood decreases time to diagnosis.
Read More
The Evolution of Syphilis Testing
With syphilis rates on the rise, a reverse screening algorithm offers high clinical value.
Read More
Study Reveals Rapid Detection of Pathogens and Antibiotic Resistance with DNAe’s Bloodstream Infection Technology
Time to detection by the LiDia bloodstream infection method was significantly shorter than the time required for standard-of-care blood culture testing.
Read More